FRI-1603 Synthesis and Structure-activity Relationship of Disubstituted Benzamides as a Novel Class of Antimalarial Agents

Friday, October 12, 2012: 9:00 AM
Hall 4E/F (WSCC)
Yandira Salinas, BS , Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN
Michele Connelly , Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN
Katsuhiko Mitachi, PhD , Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN
Nicholas Jensen , Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN
Taotao Ling, PhD , Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN
Fatima Rivas, PhD , Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN
Malaria is a devastating world health problem. Using a compound library screening approach, a novel series of disubstituted benzamide compounds was identified to have significant activity against malaria strains 3D7 and K1.  These compounds represent a new antimalarial molecular scaffold, which demonstrate EC50 values of 60 and 430 nM against strains 3D7 and K1, respectively.  Herein we report our findings on the efficient synthesis, structure-activity relationships, and biological activity of this new class of antimalarial agents.